1.
Determination of Enantiomers in Entecavir Dispersible Tablets by HPLC-Chiral Stationary Phase
HPLC法测定恩替卡韦分散片的异构体
2.
Analysis of the curative efficacy in patients with chronic hepatitis B treated with entecavir
恩替卡韦治疗慢性乙型肝炎疗效分析
3.
Early results of entecavir associated with kushenin to treat chronicity type B hepatitis of 41 patients
恩替卡韦联合苦参素片治疗慢性乙型肝炎41例
4.
Effect of Jian'gan Powder Combining Entecavir on Serum Fibrosis Indexes in Hepatitis B Patients with Early Liver Cirrhosis
健肝散联合恩替卡韦片对乙型肝炎早期肝硬化血清纤维化指标的影响
5.
Anti-virus therapy of entecavir in the treatment of chronic hepatitis B at the initial stage
恩替卡韦治疗慢性乙型肝炎118例效果分析
6.
Antiviral effect of entecavir in patients with severe chronic hepatitis B
慢性重型乙型肝炎患者恩替卡韦治疗效果分析
7.
Clinical Evaluation of entecavir in treatment of chronic hepatitis B
恩替卡韦治疗慢性乙型肝炎临床评价
8.
Clinical observation about anti-virus therapy of entecavir in treating chronic hepatitis B at the initial stage
恩替卡韦对慢性乙型肝炎抗病毒治疗的效果分析
9.
Clinical Observation About Anti-virus Therapy of Entecavir and Interferon in Treating Chronic Hepatitis B at the Initial Stage
恩替卡韦和干扰素对慢性乙型肝炎抗病毒治疗的效果分析
10.
Resistance assay in chronic hepatitis B patients who underwent virological breakthrough during entecavir treatment
恩替卡韦治疗后出现病毒学突破的慢性乙型肝炎患者的耐药分析
11.
Resistance analysis of entecavir-refractory in chronic hepatitis B patients
恩替卡韦治疗失败的慢性乙型肝炎患者耐药分析20例
12.
Synthesis of the Key Intermediate of the Anti-HBV Agent Entecavir;
抗乙肝药物恩替卡韦重要中间体的合成
13.
The use of entecavir in the treatment of lamivudine-resistant chronic hepatitis B
恩替卡韦在拉米夫定耐药患者中的应用
14.
One-year therapeutic effect of Entecavir for treating chronic hepatitis B
恩替卡韦治疗慢性乙型肝炎1年期疗效
15.
The efficacy of entecavir in patients with chronic hepatitis B treatment for 48 weeks
恩替卡韦治疗慢性乙型肝炎48周疗效观察
16.
Investigation of the liver failure patients infected with hepatitis B virus treated with entecavir
恩替卡韦治疗乙型肝炎肝衰竭患者临床研究
17.
Clinical observation of Entecavir in treating chronic hepatitis B patients
恩替卡韦治疗慢性乙型肝炎的临床观察
18.
Hyperthyoidism occurring during treatment with entecavir
恩替卡韦治疗期间发生甲状腺功能亢进